Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT
- Status
- COMPLETED
- Phase
- PHASE2
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
- Status
- COMPLETED
- Phase
- PHASE3
Therapy for Children With Advanced Stage Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
iCAT for Recurrent/Refractory/HR Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
- Status
- COMPLETED
- Phase
- NA
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
- Status
- COMPLETED
- Phase
- NA
Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL
- Status
- COMPLETED
- Phase
- PHASE1
ch14.18/CHO Bridging Study
- Status
- COMPLETED
- Phase
- PHASE1
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
- Status
- RECRUITING
- Phase
- PHASE3
Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma
- Status
- COMPLETED
- Phase
- N/A